John Pennett Presents at Conference Exploring Government Regulation of Prescription Drug Pricing
This morning, John Pennett, Partner-in-Charge of the firm’s Life Sciences Group, presented at a conference relating to Drug Pricing and Reimbursement Fundamentals for Government Payor Programs - Advanced Strategies for Counsel and their Government Pricing Clients on Medicaid and Medicare Pricing and Reimbursement. John was part of the Working Group on Drug Pricing and Reimbursement Fundamentals for Government Payor Programs examining current rebate and pricing essentials while exploring potential changes to these methodologies under the proposed AMP Rule, other components of Health Care Reform and the current political atmosphere.
The conference, which runs through Wednesday and is being held at the Doubletree Suites Times Square, in New York City, focuses on topics such as Medicare Part D Discount program, Medicare Part B Drug Pricing and other drug pricing methodologies and proposed rules. Click here for more information on the conference.